Literature DB >> 19556930

Limitations of the dye-based method for determining vaginal applicator use in microbicide trials.

Michele N Austin1, Lorna K Rabe, Sharon L Hillier.   

Abstract

BACKGROUND: A dye-based method for determining applicator usage in microbicide trials has been developed to assess whether applicators have been exposed to vaginal fluid. Our objective was to evaluate this method on polypropylene HTI applicators that are being widely used in several effectiveness trials of microbicides.
METHODS: Study participants enrolled in a clinical trial assessing SPL7013 (VivaGel) inserted gel intravaginally twice daily for 14 days and returned used and unused applicators. Before staining, smears were prepared from each participant-inserted applicator, Gram stained and assessed independently for the presence of vaginal cells and bacteria. Of the 169 participant-inserted applicators, 168 (99%) had vaginal cells identified by Gram stain. PARTICIPANT: Inserted applicators were stained with a 0.05% FD & C blue dye No. 1 solution and compared with 70 inserted positive control applicators and 70 unused negative control applicators. Intravaginally inserted applicators should stain turquoise, whereas unused applicators should not retain any stain. The individual responsible for labeling and preparing the applicators did not serve as an evaluator.
RESULTS: : Under optimized conditions, the sensitivity and specificity ranged from 81% to 95% and 86% to 93%, respectively for single use and unused applicators. The dye-based method was only 47% to 77% sensitive for participant-inserted applicators obtained from women using gel twice daily.
CONCLUSION: The dye test for HTI polypropylene applicators had a sensitivity of 47% to 95%, depending on the evaluator and whether gel was present in the vagina. The sensitivity was decreased with multiple gel applications. The dye-based method cannot be recommended for HTI polypropylene applicators to monitor product adherence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556930      PMCID: PMC2760219          DOI: 10.1097/OLQ.0b013e3181972397

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  15 in total

1.  The differential effects of face-to-face and computer interview modes.

Authors:  Jessica Clark Newman; Don C Des Jarlais; Charles F Turner; Jay Gribble; Phillip Cooley; Denise Paone
Journal:  Am J Public Health       Date:  2002-02       Impact factor: 9.308

Review 2.  Vaginal microbicides.

Authors:  Rebecca Flynn O'Brien
Journal:  Adolesc Med Clin       Date:  2006-10

3.  Audio computer assisted interviewing to measure HIV risk behaviours in a clinic population.

Authors:  S M Rogers; G Willis; A Al-Tayyib; M A Villarroel; C F Turner; L Ganapathi; J Zenilman; R Jadack
Journal:  Sex Transm Infect       Date:  2005-12       Impact factor: 3.519

4.  Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  D S Metzger; B Koblin; C Turner; H Navaline; F Valenti; S Holte; M Gross; A Sheon; H Miller; P Cooley; G R Seage
Journal:  Am J Epidemiol       Date:  2000-07-15       Impact factor: 4.897

5.  Validity of self-reported 'safe sex' among female sex workers in Mombasa, Kenya--PSA analysis.

Authors:  M F Gallo; F M Behets; M J Steiner; S C Thomsen; W Ombidi; S Luchters; C Toroitich-Ruto; M M Hobbs
Journal:  Int J STD AIDS       Date:  2007-01       Impact factor: 1.359

Review 6.  HIV/AIDS in women: an expanding epidemic.

Authors:  Thomas C Quinn; Julie Overbaugh
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

7.  Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen.

Authors:  Maria F Gallo; Frieda M Behets; Markus J Steiner; Marcia M Hobbs; Theresa Hatzell Hoke; Kathleen Van Damme; Louisette Ralimamonjy; Leonardine Raharimalala; Myron S Cohen
Journal:  Sex Transm Dis       Date:  2006-08       Impact factor: 2.830

8.  A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.

Authors:  R E Roddy; L Zekeng; K A Ryan; U Tamoufé; S S Weir; E L Wong
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

9.  Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials.

Authors:  Andrea R Wallace; Aaron Teitelbaum; Livia Wan; Maria Gloria Mulima; Laura Guichard; Stephanie Skoler; Stephanie Skiler; Hlengiwe Vilakazi; Fridda S Mapula; Jasmine Rossier; Sumen N Govender; Pekka Lahteenmaki; Robin A Maguire; David M Phillips
Journal:  Contraception       Date:  2007-05-11       Impact factor: 3.375

10.  Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

Authors:  Nancy S Padian; Ariane van der Straten; Gita Ramjee; Tsungai Chipato; Guy de Bruyn; Kelly Blanchard; Stephen Shiboski; Elizabeth T Montgomery; Heidi Fancher; Helen Cheng; Michael Rosenblum; Mark van der Laan; Nicholas Jewell; James McIntyre
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

View more
  17 in total

1.  An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.

Authors:  Sharon A Abbott; Barbara A Friedland; Avina Sarna; Lauren L Katzen; Ulrike Rawiel; Aylur K Srikrishnan; C S Shalini; Waimar Tun; Christine A Kelly; Suniti Solomon; Barbara S Mensch
Journal:  AIDS Behav       Date:  2013-07

Review 2.  Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies.

Authors:  Q Abdool Karim; C Baxter; S Abdool Karim
Journal:  BJOG       Date:  2014-10       Impact factor: 6.531

3.  Interventions to prevent sexually transmitted infections, including HIV infection.

Authors:  Jeanne M Marrazzo; Willard Cates
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

4.  Fecal Coliform Bacterial Detection to Assess Enema Adherence in HIV Prevention Clinical Studies.

Authors:  Wutyi S Aung; Rahul P Bakshi; Jennifer Breakey; James E Johnson; Craig W Hendrix; Ethel Weld; Edward J Fuchs; Mark A Marzinke
Journal:  AIDS Behav       Date:  2019-01

5.  Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women.

Authors:  Salim S Abdool Karim; Barbra A Richardson; Gita Ramjee; Irving F Hoffman; Zvavahera M Chirenje; Taha Taha; Muzala Kapina; Lisa Maslankowski; Anne Coletti; Albert Profy; Thomas R Moench; Estelle Piwowar-Manning; Benoît Mâsse; Sharon L Hillier; Lydia Soto-Torres
Journal:  AIDS       Date:  2011-04-24       Impact factor: 4.177

6.  Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations.

Authors:  Anke Hemmerling; William G Harrison; Joelle Morgan Brown; Barbara Moscicki; Maria Oziemkowska; Elizabeth A Bukusi; Craig R Cohen
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

7.  Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial.

Authors:  Tanuja N Gengiah; Leila E Mansoor; Michele Upfold; Anushka Naidoo; Nonhlanhla Yende-Zuma; Angela D M Kashuba; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  AIDS Behav       Date:  2014-05

8.  Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials.

Authors:  Ariane van der Straten; Helen Cheng; Barbara Mensch; Barbara Friedland; Lauren Katzen; Sarah Littlefield; Niall Buckley; Lilia Espinoza; Marla J Keller; Betsy C Herold; Mark H Einstein
Journal:  Sex Transm Dis       Date:  2013-12       Impact factor: 2.830

9.  Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex.

Authors:  Marla J Keller; Niall Buckley; Lauren L Katzen; Jennifer Walsh; Barbara Friedland; Sarah Littlefield; Juan Lin; Xiaonan Xue; Terri Cornelison; Betsy C Herold; Mark H Einstein
Journal:  Sex Transm Dis       Date:  2013-12       Impact factor: 2.830

10.  Use of a novel technology to track adherence to product use in a microbicide trial of short duration (MTN-007).

Authors:  Cheng-Shiun Leu; Marina Mabragaña; Rebecca Giguere; Curtis Dolezal; Alex Carballo-Diéguez; Ian McGowan
Journal:  AIDS Behav       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.